4153.TWO · DIVA LABS.
Taiwan · RS rating 40 · As of 2026-10-08
| Price | 30.90 TWD |
|---|---|
| 1-day change | -2.4% |
| RS rating (overall / 1M / 3M / 12M) | 40 / 20 / 61 / 30 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 37 / 25 / 50 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +25.5% |
| Sales growth Q/Q | +9.9% |
| Distance from 52-week high | +20.7% |
| Market cap (USD) | $58.0M |